NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 112 filers reported holding NEVRO CORP in Q2 2015. The put-call ratio across all filers is 2.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $56,625,000 | -22.5% | 779,315 | +11.3% | 0.01% | -33.3% |
| Q3 2016 | $73,075,000 | +53.2% | 700,023 | +8.2% | 0.02% | +36.4% |
| Q2 2016 | $47,706,000 | +90.4% | 646,769 | +45.3% | 0.01% | +83.3% |
| Q1 2016 | $25,051,000 | -18.0% | 445,266 | -1.6% | 0.01% | -14.3% |
| Q4 2015 | $30,533,000 | +52.3% | 452,278 | +4.6% | 0.01% | +40.0% |
| Q3 2015 | $20,049,000 | -10.2% | 432,185 | +4.1% | 0.01% | 0.0% |
| Q2 2015 | $22,321,000 | +108.1% | 415,274 | +85.5% | 0.01% | +66.7% |
| Q1 2015 | $10,728,000 | +25.6% | 223,835 | +1.3% | 0.00% | +50.0% |
| Q4 2014 | $8,543,000 | – | 220,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |